To Resect or Not to Resect, That is the Question: Neoadjuvant Therapy as the Necessary Gatekeeper for Surgical Treatment in High-Risk Intrahepatic Cholangiocarcinoma
本文未提供摘要，请点击“查看全文”查看完整内容。